Greenwich LifeSciences
GLSI
#8391
Rank
NZ$0.51 B
Marketcap
NZ$35.19
Share price
-2.73%
Change (1 day)
142.44%
Change (1 year)

Greenwich LifeSciences (GLSI) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$16.22 Million

According to Greenwich LifeSciences's latest financial reports the company's total assets are NZ$16.22 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Greenwich LifeSciences - Total assets on balance sheet (from 2019 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$10.66 M46.96%
2024-12-31NZ$7.25 M-34.37%
2023-12-31NZ$11.06 M-47.89%
2022-12-31NZ$21.22 M-46.73%
2021-12-31NZ$39.84 M0.26%
2020-12-31NZ$39.74 M100257.86%
2019-12-31NZ$0.03 M-75.53%
2018-12-31NZ$0.16 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Organovo
ONVO
NZ$26.78 M 65.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
NZ$0.36 B 2,178.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$1.74 B 10,665.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
NZ$1.45 B 8,858.54% Jersey